• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

10/11/2023 15:47

Bacil Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th November 2023.

1. Considered and approved the Un-audited Financial Results along with Statements of Assets and Liabilities and Cash Flow Statement of the Company for the Quarter and half year ended 30th September, 2023 along with Limited Review Report for the Quarter ended 30th September, 2023. \r\n\r\n2. Other routine business with the permission of the Chair.\r\n